Saturday, February 2, 2019

An injection to treat forehead wrinkles is set to rival Allergan's Botox after U.S. regulators approved Evolus Inc's cheaper treatment on Friday, sending its shares up about 5 percent after the bell.


from Reuters: Health News https://reut.rs/2SmigH9

Related Posts:

  • LATEST HEALTH NEWSMore than 34,000 people across Europe caught measles in the first two months of 2019, with the vast majority of cases in Ukraine, the World Health Organization said on Tuesday as it urged authorities to ensure vulnerable peop… Read More
  • LATEST HEALTH NEWSThree out of four Americans believe children should be vaccinated against measles even if their parents object, a Reuters/Ipsos poll found, showing little sympathy for the anti-vaccination movement that U.S. officials blame f… Read More
  • LATEST HEALTH NEWSGV, Alphabet Inc's venture capital arm, led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases. from Reuters: Health … Read More
  • LATEST HEALTH NEWSJacobus Pharmaceutical Co Inc on Monday won U.S. approval for the first drug to treat children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder. from Reuters: Health News https://reut.rs/2H4HlzL … Read More
  • LATEST HEALTH NEWS(Reuters Health) - Physician Compare, a U.S. website created to help patients find high-quality doctors, is missing so much information on individual providers that it may not be helpful, a new study suggests. from Reute… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner